Bebtelovimab: The FDA-approved Monoclonal Antibody for Treating Patients with Mild-to-Moderate COVID-19

Files

tms-2-3-130706.pdf (87.54 KB)

Date

Authors

Pouya Safarzadeh Kozani

Narges Baharifar

Setareh Dashti Shokoohi

Seyed Mohamad Javad Mirarefin

Pooria Safarzadeh Kozani

Abdolkarim Sheikhi

Publisher

Brieflands

DOI

https://doi.org/10.5812/tms-130706

Abstract

This article does not have an abstract.

URI

https://brieflands.com/journals/jai/articles/130706

Collections

Trends in Medical Sciences